MedPath

Levetiracetam

These highlights do not include all the information needed to use LEVETIRACETAM oral solution USP safely and effectively. See full prescribing information for Levetiracetam Oral Solution USP. Levetiracetam Oral Solution USP Initial U.S. Approval: 1999

Approved
Approval ID

3a472ddb-ecde-4d51-adbc-d95a96cf85d3

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 14, 2021

Manufacturers
FDA

PINNACLE PHARMA LLC

DUNS: 081126970

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

LEVETIRACETAM

PRODUCT DETAILS

NDC Product Code81646-116
Application NumberANDA201157
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateMay 13, 2021
Generic NameLEVETIRACETAM

INGREDIENTS (9)

LEVETIRACETAMActive
Quantity: 500 mg in 5 mL
Code: 44YRR34555
Classification: ACTIB
ACESULFAME POTASSIUMInactive
Code: 23OV73Q5G9
Classification: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
MALTITOLInactive
Code: D65DG142WK
Classification: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CITRATE, UNSPECIFIED FORMInactive
Code: 1Q73Q2JULR
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
Levetiracetam - FDA Approval | MedPath